Matches in SemOpenAlex for { <https://semopenalex.org/work/W44983435> ?p ?o ?g. }
- W44983435 endingPage "213" @default.
- W44983435 startingPage "201" @default.
- W44983435 abstract "Many contraceptive methods have been developed for fertility regulation, either reversible or irreversible, in males and females. Oral contraceptives have been considered the most popular form of reversible contraception. However, they must be taken consistently, on a daily basis for 21 or 28 days of each menstrual cycle, in order to achieve the maximal outcomes of contraception. Moreover, their contraceptive efficacy has been reportedly affected by their interactions with many drug products taken concurrently for other conditions. To resolve the dilemma of daily compliance and the risk of potential interactions with drugs taken orally, several non-traditional delivery systems have been developed to permit contraceptive agents and their combinations to be administered via a non-oral route, and also at a lesser frequency of administration, so as to enhance treatment compliance, maximize therapeutic outcomes, and minimize adverse effects. One typical example is the successful development of the ethinylestradiol/norelgestromin patch for achieving contraception in females via transdermal delivery. With topical application on intact skin, each patch delivers a combination of norelgestromin and ethinylestradiol for a week. With a treatment schedule of 3 weeks with a patch on and 1 week without a patch for each menstrual cycle, the ethinylestradiol/norelgestromin patch has achieved a clinical efficacy that is considered bioequivalent to oral contraceptives (with an unintended pregnancy rate of 0.8% per woman-year for the patch versus 0.1% per woman-year for the combined oral contraceptive).Stimulated by the marketing success of the ethinylestradiol/norelgestromin transdermal contraceptive patch, and a growing recognition of the therapeutic benefits realized by delivering an orally inactive progestin via a transdermal route, other transdermal drug delivery systems (DDS), such as transdermal gels and a metered-dose transdermal spray system, have also been developed. Further transdermal contraceptive patches have also been developed. One of these is similar to the ethinylestradiol/norelgestromin patch, in that it is fabricated from an adhesive polymer matrix diffusion-controlled DDS; however, it has a two times smaller patch size (to minimize localized reactions at the application site). This was made possible by substituting norelgestromin with a more potent progestin called gestodene, that has a higher skin permeation rate. The other transdermal patch that has been developed employs a microreservoir partition-controlled delivery system, to provide dual-controlled delivery of estradiol (a natural estrogen) and levonorgestrel (another potent synthetic progestin) at constant rates (zero-order kinetics). Clinical studies have demonstrated that these two new patch systems may be attractive alternative forms of contraception, since ovulation inhibition has been achieved in all subjects who wear the transdermal patch for 3 weeks, replacing it on a weekly basis.A transdermal gel has been formulated to contain elcometrine, which has a progestational potency that is 100 times that of progesterone but is orally inactive, in an alcoholic solution. Preliminary clinical studies have indicated that suppression of ovulation was achieved in the majority of subjects receiving daily application of the transdermal gel. To address the problems associated with the dosing accuracy of the transdermal gel, due to difficulty controlling the area and size of the application site, the feasibility of delivering the transdermal gel from a metered-dose transdermal spray system is currently under evaluation by the Population Council." @default.
- W44983435 created "2016-06-24" @default.
- W44983435 creator A5003833043 @default.
- W44983435 creator A5062014001 @default.
- W44983435 date "2006-01-01" @default.
- W44983435 modified "2023-09-24" @default.
- W44983435 title "Transdermal Contraceptive Patches" @default.
- W44983435 cites W101212779 @default.
- W44983435 cites W120175188 @default.
- W44983435 cites W120970114 @default.
- W44983435 cites W1863943753 @default.
- W44983435 cites W1965737340 @default.
- W44983435 cites W1966525563 @default.
- W44983435 cites W1974120683 @default.
- W44983435 cites W1977492233 @default.
- W44983435 cites W1979454140 @default.
- W44983435 cites W1979486893 @default.
- W44983435 cites W1989532259 @default.
- W44983435 cites W1992230467 @default.
- W44983435 cites W2004408730 @default.
- W44983435 cites W2004631794 @default.
- W44983435 cites W2005117222 @default.
- W44983435 cites W2016237152 @default.
- W44983435 cites W2018246155 @default.
- W44983435 cites W2021429450 @default.
- W44983435 cites W2028354053 @default.
- W44983435 cites W2029826907 @default.
- W44983435 cites W2030461184 @default.
- W44983435 cites W2031459387 @default.
- W44983435 cites W2039841692 @default.
- W44983435 cites W2044555929 @default.
- W44983435 cites W2046221517 @default.
- W44983435 cites W2047113661 @default.
- W44983435 cites W2054400702 @default.
- W44983435 cites W2058455525 @default.
- W44983435 cites W2067885280 @default.
- W44983435 cites W2069107664 @default.
- W44983435 cites W2088348726 @default.
- W44983435 cites W2091121708 @default.
- W44983435 cites W2092336364 @default.
- W44983435 cites W2092924786 @default.
- W44983435 cites W2099018240 @default.
- W44983435 cites W2108145828 @default.
- W44983435 cites W2108895631 @default.
- W44983435 cites W2131028037 @default.
- W44983435 cites W2148402834 @default.
- W44983435 cites W2158600879 @default.
- W44983435 cites W2164437454 @default.
- W44983435 cites W2165491462 @default.
- W44983435 cites W2166028293 @default.
- W44983435 cites W2166531773 @default.
- W44983435 cites W2315216244 @default.
- W44983435 cites W250982179 @default.
- W44983435 cites W4245231609 @default.
- W44983435 cites W45277116 @default.
- W44983435 doi "https://doi.org/10.2165/00137696-200604040-00003" @default.
- W44983435 hasPublicationYear "2006" @default.
- W44983435 type Work @default.
- W44983435 sameAs 44983435 @default.
- W44983435 citedByCount "1" @default.
- W44983435 crossrefType "journal-article" @default.
- W44983435 hasAuthorship W44983435A5003833043 @default.
- W44983435 hasAuthorship W44983435A5062014001 @default.
- W44983435 hasConcept C126322002 @default.
- W44983435 hasConcept C131872663 @default.
- W44983435 hasConcept C197934379 @default.
- W44983435 hasConcept C205679159 @default.
- W44983435 hasConcept C2775842315 @default.
- W44983435 hasConcept C2777288759 @default.
- W44983435 hasConcept C2777956591 @default.
- W44983435 hasConcept C2778239997 @default.
- W44983435 hasConcept C2779058012 @default.
- W44983435 hasConcept C2779076696 @default.
- W44983435 hasConcept C2780186607 @default.
- W44983435 hasConcept C2780620491 @default.
- W44983435 hasConcept C2908647359 @default.
- W44983435 hasConcept C29456083 @default.
- W44983435 hasConcept C2986817661 @default.
- W44983435 hasConcept C71315377 @default.
- W44983435 hasConcept C71924100 @default.
- W44983435 hasConcept C98274493 @default.
- W44983435 hasConcept C99454951 @default.
- W44983435 hasConceptScore W44983435C126322002 @default.
- W44983435 hasConceptScore W44983435C131872663 @default.
- W44983435 hasConceptScore W44983435C197934379 @default.
- W44983435 hasConceptScore W44983435C205679159 @default.
- W44983435 hasConceptScore W44983435C2775842315 @default.
- W44983435 hasConceptScore W44983435C2777288759 @default.
- W44983435 hasConceptScore W44983435C2777956591 @default.
- W44983435 hasConceptScore W44983435C2778239997 @default.
- W44983435 hasConceptScore W44983435C2779058012 @default.
- W44983435 hasConceptScore W44983435C2779076696 @default.
- W44983435 hasConceptScore W44983435C2780186607 @default.
- W44983435 hasConceptScore W44983435C2780620491 @default.
- W44983435 hasConceptScore W44983435C2908647359 @default.
- W44983435 hasConceptScore W44983435C29456083 @default.
- W44983435 hasConceptScore W44983435C2986817661 @default.
- W44983435 hasConceptScore W44983435C71315377 @default.